About Newtech Pharmaceuticals Private Limited
Data last updated:
Newtech Pharmaceuticals Private Limited is a private limited company based in Saharanpur, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 June 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24290UP2016PTC083928. Its GSTIN is 09AAFCN2743K1Z7 (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9 Lakh. It is led by directors Atul Arora and Neerja Arora.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Village Chajjpura Pargana Harora, Saharanpur, Uttar Pradesh, India – 247001.
As per the financials filed for FY 2024, the company reported a revenue of ₹42.14 Lakh, a decline of 49% compared to the previous year. For the same year it recorded a net profit of ₹6,004 (net margin 0.1%) and EBITDA of ₹3.49 Lakh (EBITDA margin 8.3%). Revenue has declined at a compounded annual rate (CAGR) of 30% over three years and 15% over five years.
As per MCA filings, the company has open charges of ₹38.5 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website newtechpharmaceuticals.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressVillage Chajjpura Pargana Harora, Saharanpur, Uttar Pradesh, India – 247001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Newtech Pharmaceuticals Private Limited
The main business activity of Newtech Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Newtech Pharmaceuticals Private Limited FY 2025 filings available
Newtech Pharmaceuticals Private Limited reported revenue of ₹42.14 Lakh (down 49% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Newtech Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 15% over five years, including a 49% fall in the latest year. EBITDA fell 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Newtech Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.49 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹6,004 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Newtech Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Newtech Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Newtech Pharmaceuticals Private Limited
Newtech Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vardhman Biotech Private Limited | ₹42.46 Lakh (FY 2025) | •••• | •••• | -6.0% | •••• | New Delhi, Delhi, India |
| Leonova Pharmaceuticals Private Limited | ₹42.46 Lakh (FY 2025) | •••• | •••• | -3.0% | •••• | Bannerghatta, Karnataka, India |
| Supreme Lubricants Private Limited | ₹42.41 Lakh (FY 2024) | •••• | •••• | 45.0% | •••• | Hyderabad, Telangana, India |
| Apc Pharmaceuticals and Chemicals Private Limited | ₹42.38 Lakh (FY 2025) | •••• | •••• | 31.0% | •••• | Santacruz West, Maharashtra, India |
| Medicsy Life Science Private Limited | ₹42.24 Lakh (FY 2025) | •••• | •••• | 19.0% | •••• | Patna, Bihar, India |
| Newtech Pharmaceuticals Private Limited this company | ₹42.14 Lakh (FY 2024) | •••• | •••• | -49.0% | •••• | Saharanpur, Uttar Pradesh, India |
| Medicon Health Care Private Limited | ₹42.13 Lakh (FY 2024) | •••• | •••• | -11.0% | •••• | Navi Mumbai, Maharashtra, India |
| Newel Lifesciences Private Limited | ₹42 Lakh (FY 2024) | •••• | •••• | -37.0% | •••• | Ahmedabad, Gujarat, India |
| SRBM Lifecare Private Limited | ₹41.96 Lakh (FY 2025) | •••• | •••• | 16.0% | •••• | Gopalganj, Bihar, India |
| Epila Formulations & Services Private Limited | ₹41.96 Lakh (FY 2025) | •••• | •••• | 31.0% | •••• | Patna, Bihar, India |
| Gavisun Healthcare Private Limited | ₹41.88 Lakh (FY 2025) | •••• | •••• | -69.0% | •••• | Panchkula, Haryana, India |
Peers are the five companies nearest above and the five nearest below Newtech Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Newtech Pharmaceuticals Private Limited
Newtech Pharmaceuticals Private Limited is audited by MUKESH K GOEL & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MUKESH K GOEL & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Newtech Pharmaceuticals Private Limited
Newtech Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Atul Arora | Director | 09 Jun 2016 | 10 Years 4 Months | Current |
| Neerja Arora | Director | 09 Jun 2016 | 10 Years 4 Months | Current |
Ownership and Shareholding of Newtech Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Newtech Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Sep 2019 | Yes Bank Limited | ₹38.5 Lakh | Open |
Total charge records: 1 View all charges
MSME Payment Delays by Newtech Pharmaceuticals Private Limited
Newtech Pharmaceuticals Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 14 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Indus Plast Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Newtech Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Newtech Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Newtech Pharmaceuticals Private Limited
Newtech Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Atul Arora was appointed as Director on 09 Jun 2016.
Credit Ratings, Litigation & Regulatory Alerts for Newtech Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Newtech Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Newtech Pharmaceuticals Private Limited
Newtech Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCN2743K1Z7 | Uttar Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Newtech Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Newtech Pharmaceuticals Private Limited
Newtech Pharmaceuticals is an active private limited company based in Saharanpur, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 June 2016 (10+ years old) and is registered under CIN U24290UP2016PTC083928.
Newtech Pharmaceuticals reported revenue of ₹42.14 Lakh for FY 2024 (down 49% YoY).
Newtech Pharmaceuticals has 2 current directors:
- Atul Arora - Director
- Neerja Arora - Director
Newtech Pharmaceuticals reported a net profit of ₹6,004 (net margin 0.1%) and EBITDA of ₹3.49 Lakh (EBITDA margin 8.3%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Newtech Pharmaceuticals is -30% over three years and -15% over five years. In the latest year (FY 2024) revenue fell 49%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Newtech Pharmaceuticals is 09AAFCN2743K1Z7, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Newtech Pharmaceuticals is U24290UP2016PTC083928. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Newtech Pharmaceuticals was incorporated on 09 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Newtech Pharmaceuticals by revenue are Vardhman Biotech Private Limited, Leonova Pharmaceuticals Private Limited, Supreme Lubricants Private Limited, Apc Pharmaceuticals and Chemicals Private Limited, Medicsy Life Science Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Atul Arora was appointed as Director on 09 Jun 2016. Neerja Arora was appointed as Director on 09 Jun 2016.
Newtech Pharmaceuticals has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 14 overdue payments to 3 micro and small suppliers. The latest return was filed on 08 Jun 2019.
Newtech Pharmaceuticals can be reached through the website newtechpharmaceuticals.com. Its registered office is in Saharanpur, Uttar Pradesh, India.